Project Engineer – (Pharma) Facilities Engineering

Designer Group

The Position

  • Reporting to the Project Team Lead.
  • Responsible for professionally and systematically scope, define, design, develop, and implement Projects in an API Pharma environment.
  • Examples of these projects include large-scale process modifications, major utility upgrades, process upgrades and civil works.
  • As safety is a primary focus-area, being able to work effectively while adhering to strict health and safety protocols is a requirement.

Qualifications / Experience

  • A Mechanical Engineer or a suitably qualified Engineer, preferably Degree Qualified with a broad understanding of site relevant engineering disciplines, such as Mechatronic, Process, Reliability, Chemical (ATEX) or Materials is preferred.
  • Additional areas of expertise such as Pharma or Automation, Electrical, Process, Safety, Quality and Test are also highly desirable.
  • Minimum of 5+ years’ experience in a similar role, in a continuous process/manufacturing environment, preferred.

Summary Key Tasks and Responsibilities:

  • A proven track record of planning engineering projects with a demonstrated outcome of on-time performance.
  • Experience managing the financial performance of engineering projects, including budgeting and safety/quality risk management. Experience using systems such as SAP and project management tools preferred.
  • Expert understanding of the project management process; programming, scope development, design development, implementation, project closeout.
  • Experience participating in multi-discipline cross-functional teams such as Production, QA and EHS.
  • Experience of designing projects that are reliable and safe for those who use them and for the environment.
  • Ensuring compliance with all GMP regulations.
  • Ability to consider the potential impact construction and ‘on-time performance’ will have on the business should it cause an interruption.

 

 

To apply for this job email your details to IRLcareers@designergrp.com

Comments are closed.